KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Nektar Therapeutics (NKTR) Asset Utilization Ratio (2016 - 2025)

Nektar Therapeutics (NKTR) has 15 years of Asset Utilization Ratio data on record, last reported at 0.25 in Q3 2025.

  • For Q3 2025, Asset Utilization Ratio fell 13.98% year-over-year to 0.25; the TTM value through Sep 2025 reached 0.25, down 13.98%, while the annual FY2024 figure was 0.28, 72.51% up from the prior year.
  • Asset Utilization Ratio reached 0.25 in Q3 2025 per NKTR's latest filing, down from 0.32 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.32 in Q2 2025 and bottomed at 0.07 in Q2 2021.
  • Average Asset Utilization Ratio over 5 years is 0.18, with a median of 0.17 recorded in 2023.
  • Peak YoY movement for Asset Utilization Ratio: fell 27.99% in 2021, then skyrocketed 73.79% in 2023.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.09 in 2021, then soared by 45.01% to 0.12 in 2022, then surged by 73.79% to 0.21 in 2023, then skyrocketed by 50.0% to 0.32 in 2024, then fell by 23.53% to 0.25 in 2025.
  • Per Business Quant database, its latest 3 readings for Asset Utilization Ratio were 0.25 in Q3 2025, 0.32 in Q2 2025, and 0.31 in Q1 2025.